Quantifying the impact of the COVID-19 pandemic on gastrointestinal cancer care delivery.
Nicholas R PerkonsCasey J KimChris BoedecLuke J KeeleCharles SchneiderUrsina R TeitelbaumEdgar Ben-JosefPeter E GabrielJohn P PlastarasLawrence N ShulmanAndrzej P WojcieszynskiPublished in: Cancer reports (Hoboken, N.J.) (2021)
The COVID-19 pandemic has been associated with significant disruptions to care delivery. While these effects were appreciated broadly across GI malignancies, CRC, diagnosed and managed by periodic screening, has been affected most acutely.